Blueprint Medicines (NASDAQ:BPMC) reported quarterly losses of $(1.86) per share which met the analyst consensus estimate. This is a 18.42 percent increase over losses of $(2.28) per share from the same period last year. The company reported quarterly sales of $27.30 million which beat the analyst consensus estimate of $19.01 million by 43.58 percent. This is a 227.16 percent increase over sales of $8.34 million the same period last year.
Alkaline Water Co Q1 EPS $(0.08) Misses $(0.01) Estimate, Sales $14.10M Miss $17.35M Estimate
Alkaline Water Co (NASDAQ:WTER) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.01) by 700 percent. This is a 60 percent decrease over losses of $(0.05) per share from
